Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia
โ Scribed by Raymond R. Rackley; Bin Yang; Thomas G. Pretlow; Fadi W. Abdul-Karim; Terrence J. Lewis; Nancy McNamara; Carrie M. Delmoro; Theresa P. Pretlow; Edwin L. Bradley Jr; Elroy Kursh; Martin I. Resnick
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 711 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate. Normal range of NEC was determined in 62 healthy individuals and was found to be 0.26-2.2 mg/24 hours (2 SD) with a me
The expression and activity of aromatase was evaluated in 19 individuals with benign prostatic hyperplasia (BPH) and 26 prostatic carcinoma (PC) patients to elucidate the possible biological significance of in situ estrogen production in the development of human prostatic disorders. Marked aromatase
## Background: We investigated the role of the transforming growth factor beta (tgf-beta) family in the neoplastic progression of the human prostate. ## Methods: Expression of tgf-beta mrna was measured by northern blot analysis of tissue extracts, and tgf-beta protein by immunohistochemical anal
Extracts from fruits of Sabal serrulata are used in the treatment of human benign prostatic hyperplasia (BPH). Therefore, it is of interest whether this phytopharmacon has any influence on the androgen metabolism in the human prostate. It was found that the extract IDS 89 of Sabal serrulata inhibite